ArticleThe American journal of gastroenterology2026
Steatotic Liver Disease has Surpassed Viral Hepatitis as the Leading Cause of Cirrhosis in the US Veterans Health System.
Article in The American journal of gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Starving in Plenty: Recognizing Malnutrition in Steatotic Liver Disease.Digestive diseases and sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
introductionContemporary population-level estimates of the burden of cirrhosis using the revised steatotic liver disease (SLD) nomenclature are lacking.
methodsRetrospective cohort study of patients with incident cirrhosis from 2008 to 2023 within the Veterans Health Administration.
resultsMetabolic dysfunction-associated steatotic liver disease (MASLD) has become the leading contributor to cirrhosis incidence and prevalence. Although hepatitis C virus cirrhosis has declined, it remains highly prevalent. Incident MASLD cases are balanced by deaths, whereas incident metabolic and alcohol-associated liver disease and alcohol-associated liver disease cases exceeded deaths. DISCUSSION: Substantial epidemiologic shifts in cirrhosis in the United States over the past decade, driven by the rising burden of SLD, underscore the need for multidisciplinary strategies targeting metabolic risk factors and alcohol use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.